The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications
Abstract
The recent discovery of human-induced pluripotent stem cells (iPSCs) has revolutionized the field of stem cells. iPSCs have demonstrated that biological development is not an irreversible process and that mature adult somatic cells can be induced to become pluripotent. This breakthrough is projected to advance our current understanding of many disease processes and revolutionize the approach to effective therapeutics. Despite the great promise of iPSCs, many translational challenges still remain. In this article, we review the basic concept of induction of pluripotency as a novel approach to understand cardiac regeneration, cardiovascular disease modeling and drug discovery. We critically reflect on the current results of preclinical and clinical studies using iPSCs for these applications with appropriate emphasis on the challenges facing clinical translation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, given the potential for genetic and epigenetic abnormalities to arise in culture, there is only a paucity of studies that directly assess the contribution of in vitro conditions and bioprocess variables during iPSC expansion and subsequent differentiation on immunogenic potential31–33.”
From Induced pluripotency in the context of stem cell expansion bioprocess development, optimization, and manufacturing: a roadmap to the clinic (2021) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evidence for Cardiomyocyte Renewal in Humans
Bergmann, O., Bhardwaj, R. D., Bernard, S., Zdunek, S., Barnabé-Heider, F., Walsh, S., Zupicich, J., Alkass, K., Buchholz, B. A., Druid, H., et al. (2009) · Science · doi:10.1126/science.1164680 · Cited by 3,130
Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors
Ieda, M., Fu, J.-D., Delgado-Olguin, P., Vedantham, V., Hayashi, Y., Bruneau, B. G., & Srivastava, D. (2010) · Cell · doi:10.1016/j.cell.2010.07.002 · Cited by 2,454
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Chemically defined generation of human cardiomyocytes
Burridge, P. W., Matsa, E., Shukla, P., Lin, Z. C., Churko, J. M., Ebert, A. D., Lan, F., Diecke, S., Huber, B., Mordwinkin, N. M., et al. (2014) · Nature Methods · doi:10.1038/nmeth.2999 · Cited by 1,606
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251
Kattman, S. J., Witty, A. D., Gagliardi, M., Dubois, N. C., Niapour, M., Hotta, A., Ellis, J., & Keller, G. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2010.12.008 · Cited by 1,159
Modelling the long QT syndrome with induced pluripotent stem cells
Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., et al. (2011) · Nature · doi:10.1038/nature09747 · Cited by 1,049
Laurent, L. C., Ulitsky, I., Slavin, I., Tran, H., Schork, A., Morey, R., Lynch, C., Harness, J. V., Lee, S., Barrero, M. J., et al. (2011) · Cell stem cell · doi:10.1016/j.stem.2010.12.003 · Cited by 890
Wang, G., McCain, M. L., Yang, L., He, A., Pasqualini, F. S., Agarwal, A., Yuan, H., Jiang, D., Zhang, D., Zangi, L., et al. (2014) · Nature Medicine · doi:10.1038/nm.3545 · Cited by 837
Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy
Sun, N., Yazawa, M., Liu, J., Han, L., Sanchez-Freire, V., Abilez, O. J., Navarrete, E. G., Hu, S., Wang, L., Lee, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003552 · Cited by 696
Research works printed but not linked: 125
- Briggs, 1952, Transplantation of living nuclei from blastula cells into enucleated frogs’ eggs, Proc Natl Acad Sci U S A, 38, 455, 10.1073/pnas.38.5.455 · DOI · Paper page
- Gurdon, 1958, Sexually mature individuals of Xenopus laevis from the transplantation of single somatic nuclei, Nature, 182, 64, 10.1038/182064a0 · DOI · Paper page
- Cowan, 2005, Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells, Science, 309, 1369, 10.1126/science.1116447 · DOI · Paper page
- Tada, 2001, Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells, Curr Biol, 11, 1553, 10.1016/S0960-9822(01)00459-6 · DOI · Paper page
- Hochedlinger, 2006, Nuclear reprogramming and pluripotency, Nature, 441, 1061, 10.1038/nature04955 · DOI · Paper page
- Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 · DOI · Paper page
- Okita, 2007, Generation of germline-competent induced pluripotent stem cells, Nature, 448, 313, 10.1038/nature05934 · DOI · Paper page
- Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 · DOI · Paper page
- Yu, 2007, Induced pluripotent stem cell lines derived from human somatic cells, Science, 318, 1917, 10.1126/science.1151526 · DOI · Paper page
- Wernig, 2007, In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state, Nature, 448, 318, 10.1038/nature05944 · DOI · Paper page
- Park, 2008, Reprogramming of human somatic cells to pluripotency with defined factors, Nature, 451, 141, 10.1038/nature06534 · DOI · Paper page
- Aasen, 2008, Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes, Nat Biotechnol, 26, 1276, 10.1038/nbt.1503 · DOI · Paper page
- Brown, 2010, Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes, PLoS One, 5, e11373, 10.1371/journal.pone.0011373 · DOI · Paper page
- Giorgetti, 2009, Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2, Cell Stem Cell, 5, 353, 10.1016/j.stem.2009.09.008 · DOI · Paper page
- Ge, 2012, Human amniotic mesenchymal stem cell-derived induced pluripotent stem cells may generate a universal source of cardiac cells, Stem Cells Dev, 21, 2798, 10.1089/scd.2011.0435 · DOI
- Kim, 2009, Direct reprogramming of human neural stem cells by OCT4, Nature, 461, 649, 10.1038/nature08436 · DOI · Paper page
- Sun, 2009, Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells, Proc Natl Acad Sci U S A, 106, 15720, 10.1073/pnas.0908450106 · DOI · Paper page
- Zhou, 2012, Generation of human induced pluripotent stem cells from urine samples, Nat Protoc, 7, 2080, 10.1038/nprot.2012.115 · DOI · Paper page
- Mauritz, 2008, Generation of functional murine cardiac myocytes from induced pluripotent stem cells, Circulation, 118, 507, 10.1161/CIRCULATIONAHA.108.778795 · DOI · Paper page
- Narazaki, 2008, Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells, Circulation, 118, 498, 10.1161/CIRCULATIONAHA.108.769562 · DOI · Paper page
- Kawamura, 2012, Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model, Circulation, 126, S29
- Xiong, 2013, Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling, Circulation, 127, 997, 10.1161/CIRCULATIONAHA.112.000641 · DOI
- Li, 2013, Intramyocardial injection of pig pluripotent stem cells improves left ventricular function and perfusion: a study in a porcine model of acute myocardial infarction, PLoS One, 8, e66688, 10.1371/journal.pone.0066688 · doi:10.1371/journal.pone.0066688
- Sanchez-Freire, 2014, Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells, J Am Coll Cardiol, 64, 436, 10.1016/j.jacc.2014.04.056 · DOI
- Kamao, 2014, Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application, Stem Cell Reports, 2, 205, 10.1016/j.stemcr.2013.12.007 · DOI · Paper page
- Sanchez Alvarado, 2014, Rethinking differentiation: stem cells, regeneration, and plasticity, Cell, 157, 110, 10.1016/j.cell.2014.02.041 · DOI · Paper page
- Ko, 2014, Concise review: drug discovery in the age of the induced pluripotent stem cell, Stem Cells Transl Med, 3, 500, 10.5966/sctm.2013-0162 · DOI
- Lalit, 2014, Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges, Circ Res, 114, 1328, 10.1161/CIRCRESAHA.114.300556 · DOI
- Nelson, 2009, Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells, Circulation, 120, 408, 10.1161/CIRCULATIONAHA.109.865154 · DOI · Paper page
- Ahmed, 2011, Cardiac tumorigenic potential of induced pluripotent stem cells in an immunocompetent host with myocardial infarction, Regen Med, 6, 171, 10.2217/rme.10.103 · DOI
- Kim, 2015, Direct evaluation of myocardial viability and stem cell engraftment demonstrates salvage of the injured myocardium, Circ Res, 116, e40, 10.1161/CIRCRESAHA.116.304668 · DOI
- Zhang, 2011, Intramyocardial transplantation of undifferentiated rat induced pluripotent stem cells causes tumorigenesis in the heart, PLoS One, 6, e19012, 10.1371/journal.pone.0019012 · DOI
- Nussbaum, 2007, Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response, FASEB J, 21, 1345, 10.1096/fj.06-6769com · DOI · Paper page
- Arai, 2006, Dual in vivo magnetic resonance evaluation of magnetically labeled mouse embryonic stem cells and cardiac function at 1.5 T, Magn Reson Med, 55, 203, 10.1002/mrm.20702 · DOI
- Ahmed, 2011, Reprogramming of skeletal myoblasts for induction of pluripotency for tumor-free cardiomyogenesis in the infarcted heart, Circ Res, 109, 60, 10.1161/CIRCRESAHA.110.240010 · DOI
- Buccini, 2012, Cardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heart, Basic Res Cardiol, 107, 301, 10.1007/s00395-012-0301-5 · DOI
- Rulifson, 2014, Abstract 19831: in vivo molecular imaging of human pluripotent stem cell-derived cardiomyocytes in a murine myocardial injury model via a safe harbor integration of a reporter gene, Circulation, 130, A19831, 10.1161/circ.130.suppl_2.19831 · doi:10.1161/circ.130.suppl_2.19831
- Pasha, 2011, Efficient non-viral reprogramming of myoblasts to stemness with a single small molecule to generate cardiac progenitor cells, PLoS One, 6, e23667, 10.1371/journal.pone.0023667 · DOI
- Mauritz, 2011, Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction, Eur Heart J, 32, 2634, 10.1093/eurheartj/ehr166 · DOI
- Dai, 2011, Reduced collagen deposition in infarcted myocardium facilitates induced pluripotent stem cell engraftment and angiomyogenesis for improvement of left ventricular function, J Am Coll Cardiol, 58, 2118, 10.1016/j.jacc.2011.06.062 · doi:10.1016/j.jacc.2011.06.062
- Huang, 2013, Molecular strategy to reduce in vivo collagen barrier promotes entry of NCX1 positive inducible pluripotent stem cells (iPSC(NCX1+)) into ischemic (or injured) myocardium, PLoS One, 8, e70023, 10.1371/journal.pone.0070023 · DOI
- Botham, 2013, Clinical trials of adult stem cell therapy for peripheral artery disease, Methodist Debakey Cardiovasc J, 9, 201, 10.14797/mdcj-9-4-201 · DOI
- Cooke, 2015, Modulating the vascular response to limb ischemia: angiogenic and cell therapies, Circ Res, 116, 1561, 10.1161/CIRCRESAHA.115.303565 · DOI · Paper page
- Perin, 2014, Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cells, Am Heart J, 168, 667, 10.1016/j.ahj.2014.07.021 · doi:10.1016/j.ahj.2014.07.021
- Spinetti, 2008, Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies, Cardiovasc Res, 78, 265, 10.1093/cvr/cvn039 · DOI · Paper page
- Asahara, 2004, Endothelial progenitor cells for postnatal vasculogenesis, Am J Physiol Cell Physiol, 287, C572, 10.1152/ajpcell.00330.2003 · DOI · Paper page
- Clayton, 2015, Generating induced pluripotent stem cell derived endothelial cells and induced endothelial cells for cardiovascular disease modelling and therapeutic angiogenesis, Int J Cardiol, 197, 116, 10.1016/j.ijcard.2015.06.038 · DOI
- Choi, 2009, Hematopoietic and endothelial differentiation of human induced pluripotent stem cells, Stem Cells, 27, 559, 10.1634/stemcells.2008-0922 · doi:10.1634/stemcells.2008-0922 · Paper page
- Taura, 2009, Induction and isolation of vascular cells from human induced pluripotent stem cells—brief report, Arterioscler Thromb Vasc Biol, 29, 1100, 10.1161/ATVBAHA.108.182162 · DOI · Paper page
- Lai, 2013, Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells, PLoS One, 8, e57876, 10.1371/journal.pone.0057876 · DOI
- Wang, 2014, Engineering vascular tissue with functional smooth muscle cells derived from human iPS cells and nanofibrous scaffolds, Biomaterials, 35, 8960, 10.1016/j.biomaterials.2014.07.011 · DOI
- Hendry, 2008, Multimodal evaluation of in vivo magnetic resonance imaging of myocardial restoration by mouse embryonic stem cells, J Thorac Cardiovasc Surg, 136, 1028, 10.1016/j.jtcvs.2007.12.053 · DOI
- Hung, 2008, Multimodality evaluation of the viability of stem cells delivered into different zones of myocardial infarction, Circ Cardiovasc Imaging, 1, 6, 10.1161/CIRCIMAGING.108.767343 · DOI
- Terrovitis, 2008, Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart, Circulation, 117, 1555, 10.1161/CIRCULATIONAHA.107.732073 · DOI · Paper page
- Sanganalmath, 2013, Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions, Circ Res, 113, 810, 10.1161/CIRCRESAHA.113.300219 · DOI · Paper page
- Li, 2009, Imaging survival and function of transplanted cardiac resident stem cells, J Am Coll Cardiol, 53, 1229, 10.1016/j.jacc.2008.12.036 · DOI · Paper page
- Keith, 2015, “String theory” of c-kit(pos) cardiac cells: a new paradigm regarding the nature of these cells that may reconcile apparently discrepant results, Circ Res, 116, 1216, 10.1161/CIRCRESAHA.116.305557 · DOI
- Orlic, 2001, Bone marrow cells regenerate infarcted myocardium, Nature, 410, 701, 10.1038/35070587 · DOI · Paper page
- Quaini, 2002, Chimerism of the transplanted heart, N Engl J Med, 346, 5, 10.1056/NEJMoa012081 · DOI · Paper page
- Beltrami, 2001, Evidence that human cardiac myocytes divide after myocardial infarction, N Engl J Med, 344, 1750, 10.1056/NEJM200106073442303 · DOI · Paper page
- Kajstura, 1998, Myocyte proliferation in end-stage cardiac failure in humans, Proc Natl Acad Sci U S A, 95, 8801, 10.1073/pnas.95.15.8801 · DOI · Paper page
- Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143 · DOI · Paper page
- Messina, 2004, Isolation and expansion of adult cardiac stem cells from human and murine heart, Circ Res, 95, 911, 10.1161/01.RES.0000147315.71699.51 · DOI · Paper page
- Thomson, 1998, Embryonic stem cell lines derived from human blastocysts, Science, 282, 1145, 10.1126/science.282.5391.1145 · DOI · Paper page
- van Berlo, 2014, c-kit+ cells minimally contribute cardiomyocytes to the heart, Nature, 509, 337, 10.1038/nature13309 · DOI · Paper page
- Asahara, 1997, Isolation of putative progenitor endothelial cells for angiogenesis, Science, 275, 964, 10.1126/science.275.5302.964 · DOI · Paper page
- Asahara, 1999, Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization, Circ Res, 85, 221, 10.1161/01.RES.85.3.221 · DOI · Paper page
- Huang, 2010, Embryonic stem cell-derived endothelial cells engraft into the ischemic hindlimb and restore perfusion, Arterioscler Thromb Vasc Biol, 30, 984, 10.1161/ATVBAHA.110.202796 · DOI
- Hussein, 2011, Copy number variation and selection during reprogramming to pluripotency, Nature, 471, 58, 10.1038/nature09871 · DOI · Paper page
- Lister, 2011, Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells, Nature, 471, 68, 10.1038/nature09798 · DOI · Paper page
- Li, 2015, Genetic heterogeneity of induced pluripotent stem cells: results from 24 clones derived from a single C57BL/6 mouse, PLoS One, 10, e0120585, 10.1371/journal.pone.0120585 · DOI
- Cyranoski, 2013, Stem cells cruise to clinic, Nature, 494, 413, 10.1038/494413a · DOI
- Kim, 2010, Epigenetic memory in induced pluripotent stem cells, Nature, 467, 285, 10.1038/nature09342 · DOI · Paper page
- Robinton, 2012, The promise of induced pluripotent stem cells in research and therapy, Nature, 481, 295, 10.1038/nature10761 · DOI · Paper page
- Nakagawa, 2008, Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts, Nat Biotechnol, 26, 101, 10.1038/nbt1374 · DOI · Paper page
- Schlaeger, 2015, A comparison of non-integrating reprogramming methods, Nat Biotechnol, 33, 58, 10.1038/nbt.3070 · DOI · Paper page
- Uosaki, 2011, Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression, PLoS One, 6, e23657, 10.1371/journal.pone.0023657 · DOI · Paper page
- Lian, 2013, Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions, Nat Protocols, 8, 162, 10.1038/nprot.2012.150 · DOI · Paper page
- Fuerstenau-Sharp, 2015, Generation of highly purified human cardiomyocytes from peripheral blood mononuclear cell-derived induced pluripotent stem cells, PLoS One, 10, e0126596, 10.1371/journal.pone.0126596 · DOI
- Rufaihah, 2013, Human induced pluripotent stem cell-derived endothelial cells exhibit functional heterogeneity, Am J Transl Res, 5, 21
- Ribeiro, 2015, Contractility of single cardiomyocytes differentiated from pluripotent stem cells depends on physiological shape and substrate stiffness, Proc Natl Acad Sci U S A, 112, 12705, 10.1073/pnas.1508073112 · DOI · Paper page
- Zhao, 2011, Immunogenicity of induced pluripotent stem cells, Nature, 474, 212, 10.1038/nature10135 · DOI · Paper page
- de Almeida, 2014, Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance, Nat Commun, 5, 3903, 10.1038/ncomms4903 · DOI · Paper page
- Araki, 2013, Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells, Nature, 494, 100, 10.1038/nature11807 · DOI · Paper page
- Okita, 2011, A more efficient method to generate integration-free human iPS cells, Nat Methods, 8, 409, 10.1038/nmeth.1591 · DOI · Paper page
- Gourraud, 2012, The role of human leukocyte antigen matching in the development of multiethnic “haplobank” of induced pluripotent stem cell lines, Stem Cells, 30, 180, 10.1002/stem.772 · DOI · Paper page
- Tsuji, 2010, Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury, Proc Natl Acad Sci U S A, 107, 12704, 10.1073/pnas.0910106107 · DOI · Paper page
- Takemoto, 2000, Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation, N Engl J Med, 343, 1078, 10.1056/NEJM200010123431504 · DOI · Paper page
- Lee, 2013, Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies, Nat Med, 19, 998, 10.1038/nm.3267 · DOI · Paper page
- Ban, 2011, Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors, Proc Natl Acad Sci U S A, 108, 14234, 10.1073/pnas.1103509108 · DOI · Paper page
- Simpson, 2014, Engineering patient-specific valves using stem cells generated from skin biopsy specimens, Ann Thorac Surg, 98, 947, 10.1016/j.athoracsur.2014.04.075 · doi:10.1016/j.athoracsur.2014.04.075
- Parker, 1980, “Transdifferentiation” of C6 glial cells in culture, Science, 208, 179, 10.1126/science.6102413 · DOI · Paper page
- Qian, 2012, In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes, Nature, 485, 593, 10.1038/nature11044 · DOI · Paper page
- Song, 2012, Heart repair by reprogramming non-myocytes with cardiac transcription factors, Nature, 485, 599, 10.1038/nature11139 · DOI · Paper page
- Srivastava, 2015, Recent advances in direct cardiac reprogramming, Curr Opin Genet Dev, 34, 77, 10.1016/j.gde.2015.09.004 · DOI
- Yoshida, 2012, Labor pains of new technology: direct cardiac reprogramming, Circ Res, 111, 3, 10.1161/CIRCRESAHA.112.271445 · DOI
- Margariti, 2012, Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels, Proc Natl Acad Sci U S A, 109, 13793, 10.1073/pnas.1205526109 · DOI · Paper page
- Lee, 2012, Activation of innate immunity is required for efficient nuclear reprogramming, Cell, 151, 547, 10.1016/j.cell.2012.09.034 · DOI · Paper page
- Sayed, 2015, Transdifferentiation of human fibroblasts to endothelial cells: role of innate immunity, Circulation, 131, 300, 10.1161/CIRCULATIONAHA.113.007394 · DOI · Paper page
- Bhatia, 2014, Microfluidic organs-on-chips, Nat Biotechnol, 32, 760, 10.1038/nbt.2989 · DOI · Paper page
- Jiang, 2014, An induced pluripotent stem cell model of hypoplastic left heart syndrome (HLHS) reveals multiple expression and functional differences in HLHS-derived cardiac myocytes, Stem Cells Transl Med, 3, 416, 10.5966/sctm.2013-0105 · DOI
- Schenone, 2013, Target identification and mechanism of action in chemical biology and drug discovery, Nat Chem Biol, 9, 232, 10.1038/nchembio.1199 · DOI · Paper page
- Lee, 2012, Large-scale screening using familial dysautonomia induced pluripotent stem cells identifies compounds that rescue IKBKAP expression, Nat Biotechnol, 30, 1244, 10.1038/nbt.2435 · DOI · Paper page
- Guo, 2013, Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model, Toxicol Sci, 136, 581, 10.1093/toxsci/kft205 · DOI
- Navarrete, 2013, Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays, Circulation, 128, S3
- Takayama, 2014, Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes, Proc Natl Acad Sci U S A, 111, 16772, 10.1073/pnas.1413481111 · DOI · Paper page
- Adams, 2013, Functional vascular endothelium derived from human induced pluripotent stem cells, Stem Cell Reports, 1, 105, 10.1016/j.stemcr.2013.06.007 · DOI · Paper page
- Soldner, 2012, iPSC disease modeling, Science, 338, 1155, 10.1126/science.1227682 · DOI · Paper page
- Psaltis, 2006, Developing optofluidic technology through the fusion of microfluidics and optics, Nature, 442, 381, 10.1038/nature05060 · DOI · Paper page
- Kim, 2011, High-throughput single-molecule optofluidic analysis, Nat Methods, 8, 242, 10.1038/nmeth.1569 · DOI
- Agarwal, 2013, Microfluidic heart on a chip for higher throughput pharmacological studies, Lab Chip, 13, 3599, 10.1039/c3lc50350j · DOI · Paper page
- Grosberg, 2011, Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip, Lab Chip, 11, 4165, 10.1039/c1lc20557a · DOI · Paper page
- Ge, 2012, Modeling supravalvular aortic stenosis syndrome with human induced pluripotent stem cells, Circulation, 126, 1695, 10.1161/CIRCULATIONAHA.112.116996 · DOI
- Asimaki, 2014, Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathy, Sci Transl Med, 6, 240ra74, 10.1126/scitranslmed.3008008 · DOI · Paper page
- Ma, 2013, Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy, Eur Heart J, 34, 1122, 10.1093/eurheartj/ehs226 · DOI · Paper page
- Kim, 2013, Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs, Nature, 494, 105, 10.1038/nature11799 · DOI · Paper page
- Lan, 2013, Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells, Cell Stem Cell, 12, 101, 10.1016/j.stem.2012.10.010 · DOI · Paper page
- Hick, 2013, Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich's ataxia, Dis Model Mech, 6, 608
- Huang, 2011, Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification, Hum Mol Genet, 20, 4851, 10.1093/hmg/ddr424 · DOI
- Kujala, 2012, Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations, PLoS One, 7, e44660, 10.1371/journal.pone.0044660 · DOI
- Jung, 2012, Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia, EMBO Mol Med, 4, 180, 10.1002/emmm.201100194 · DOI · Paper page
- Novak, 2012, Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation, J Cell Mol Med, 16, 468, 10.1111/j.1582-4934.2011.01476.x · DOI · Paper page
- Itzhaki, 2012, Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells, J Am Coll Cardiol, 60, 990, 10.1016/j.jacc.2012.02.066 · DOI · Paper page
- Lahti, 2012, Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture, Dis Model Mech, 5, 220, 10.1242/dmm.008409 · DOI · Paper page
- Yazawa, 2011, Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome, Nature, 471, 230, 10.1038/nature09855 · DOI · Paper page
Cited by
Tan, S. Y., Mei Wong, J. L., Sim, Y. J., Wong, S. S., Mohamed Elhassan, S. A., Tan, S. H., Ling Lim, G. P., Rong Tay, N. W., Annan, N. C., Bhattamisra, S. K., et al. (2019) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2018.10.008 · Cited by 445
Colter, J., Murari, K., Biernaskie, J., & Kallos, M. S. (2021) · npj Regenerative Medicine · doi:10.1038/s41536-021-00183-7 · Cited by 33
Metadata
- Authors
- Youssef, A. A., Ross, E. G., Bolli, R., Pepine, C. J., Leeper, N. J., & Yang, P. C.
- Venue
- JACC: Basic to Translational Science
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 1
- Issue
- 6
- Pages
- 510-523
- ISSN
- 2452-302X
- Cited by
- 50
- References
- 17
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- National Center for Advancing Translational Sciences (UL1-TR001427, 1R01 HL125224)
- National Institutes of Health (HL-78825, 1T32HL098049-01A1)
- National Heart, Lung, and Blood Institute (5UM1 HL113456-02, UM1-HL113530, 5UM1-HL087366-07)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications. https://app.cochat.ai/papers/10.1016/j.jacbts.2016.06.010
- The paper
- Youssef, A. A., Ross, E. G., Bolli, R., Pepine, C. J., Leeper, N. J., & Yang, P. C. (2016). The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications. JACC: Basic to Translational Science. https://doi.org/10.1016/j.jacbts.2016.06.010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.